EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update

Smolen, J. S., Landewé, R. B. M., Bergstra, S. A., Kerschbaumer, A., Sepriano, A., Aletaha, D., Caporali, R., Edwards, C. J., Hyrich, K. L., Pope, J. E., de Souza, S., Stamm, T. A., Takeuchi, T., Verschueren, P., Winthrop, K. L., Balsa, A., Bathon, J. M., Buch, M. H., Burmester, G. R., … van der Heijde, D. (2022). EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2022 update. Annals of the Rheumatic Diseases, 82(1), 3–18. https://doi.org/10.1136/ard-2022-223356
Authors:
Josef S Smolen
Robert B M Landewé
Sytske Anne Bergstra
Andreas Kerschbaumer
Alexandre Sepriano
Daniel Aletaha
Roberto Caporali
Christopher John Edwards
Kimme L Hyrich
Janet E Pope
Savia de Souza
Tanja A Stamm
Tsutomu Takeuchi
Patrick Verschueren
Kevin L Winthrop
Alejandro Balsa
Joan M Bathon
Maya H Buch
Gerd R Burmester
Frank Buttgereit
Mario Humberto Cardiel
Katerina Chatzidionysiou
Catalin Codreanu
Maurizio Cutolo
Alfons A den Broeder
Khadija El Aoufy
Axel Finckh
João Eurico Fonseca
Jacques-Eric Gottenberg
Espen A Haavardsholm
Annamaria Iagnocco
Kim Lauper
Zhanguo Li
Iain B McInnes
Eduardo F Mysler
Peter Nash
Gyula Poor
Gorica G Ristic
Felice Rivellese
Andrea Rubbert-Roth
Hendrik Schulze-Koops
Nikolay Stoilov
Anja Strangfeld
Annette van der Helm-van Mil
Elsa van Duuren
Theodora P M Vliet Vlieland
René Westhovens
Désirée van der Heijde
Affiliated Authors:
Joan M Bathon
Author Keywords:
antirheumatic agents
arthritis, rheumatoid
biological therapy
Publication Type:
Article
Unique ID:
10.1136/ard-2022-223356
PMID:
Publication Date:
Data Source:
PubMed

Record Created: